tiprankstipranks
Chemring (GB:CHG)
LSE:CHG

Chemring (CHG) AI Stock Analysis

Compare
69 Followers

Top Page

GB

Chemring

(LSE:CHG)

74Outperform
Chemring scores well overall due to strong financial performance, strategic initiatives like the UK defense contract, and a positive technical outlook. However, the high P/E ratio and room for cash flow optimization slightly temper the score.
Positive Factors
Contract Awards
Roke will serve as Prime Contractor on STORM - Science & Technology Oriented Research & Development in Missile defence.
Revenue Visibility
The contract award will help build revenue visibility beyond the current financial year which is important.
Negative Factors
Funding Concerns
The market is concerned about the normalisation of UK government funding, which is crucial for achieving Roke's revenue growth target.
Order Intake Decline
The decline in Sensors & Information order intake has worsened, with a significant drop in Roke order intake year-over-year.

Chemring (CHG) vs. S&P 500 (SPY)

Chemring Business Overview & Revenue Model

Company DescriptionChemring Group PLC is a global technology company that specializes in the defense and security sectors. The company provides advanced technology solutions in the fields of countermeasures, sensors, and energetics. Chemring's core products include electronic warfare systems, chemical and biological threat detection, and explosive device disposal services, catering primarily to military, law enforcement, and civil defense organizations worldwide.
How the Company Makes MoneyChemring makes money through the sale of its advanced defense and security products and services, primarily to government and military clients. The company's revenue streams are divided into three main sectors: Countermeasures, Sensors, and Energetics. The Countermeasures sector involves the production of expendable decoys to protect aircraft, ships, and vehicles. The Sensors sector provides chemical and biological threat detection systems and electronic warfare technologies. The Energetics sector supplies explosive ordnance disposal products and pyrotechnics. Chemring's revenue is bolstered by long-term contracts with governments and defense departments, as well as strategic partnerships and collaborations with key industry players to enhance its technological offerings.

Chemring Financial Statement Overview

Summary
Chemring's financial performance is solid, with strong revenue growth and robust profit margins. The balance sheet is stable with manageable debt, but cash flow challenges due to capital expenditures need addressing.
Income Statement
85
Very Positive
Chemring has demonstrated strong financial performance with consistent revenue growth, evidenced by a 7.99% increase from 2023 to 2024. Gross profit margins remain robust at 100% due to the nature of the data. The EBIT margin improved to 11.38%, and the EBITDA margin to 16.20%, reflecting efficient operational management. However, the net profit margin of 7.74% suggests room for optimizing expenses or cost management.
Balance Sheet
78
Positive
The company's balance sheet shows a stable financial position with an improved debt-to-equity ratio of 0.27, indicating manageable leverage levels. The equity ratio stands at 51.47%, showing a solid equity base. Return on equity (ROE) is decent at 11.08%, though slightly lower than the previous year, suggesting potential areas for enhancing shareholder returns.
Cash Flow
70
Positive
Chemring's cash flow performance highlights some challenges, with a significant decrease in free cash flow from 2023 to 2024. The operating cash flow to net income ratio is strong at 2.05, indicating good cash generation relative to profits. However, the free cash flow to net income ratio of 0.29 suggests that capital expenditures might be impacting free cash flow generation.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
483.90M510.40M472.60M442.80M393.30M402.50M
Gross Profit
483.90M510.40M472.60M442.80M393.30M402.50M
EBIT
39.90M58.10M45.40M53.30M50.40M46.30M
EBITDA
62.40M82.70M67.10M71.20M75.50M75.10M
Net Income Common Stockholders
3.10M39.50M5.40M47.40M41.50M34.70M
Balance SheetCash, Cash Equivalents and Short-Term Investments
19.80M45.00M6.40M19.80M5.80M14.70M
Total Assets
620.10M692.10M596.40M620.10M531.50M541.40M
Total Debt
26.90M97.70M20.70M26.90M32.30M62.80M
Net Debt
7.10M52.70M14.30M7.10M26.50M48.10M
Total Liabilities
202.00M335.80M217.90M202.00M178.70M211.80M
Stockholders Equity
418.10M356.30M378.50M418.10M352.80M329.60M
Cash FlowFree Cash Flow
12.20M11.40M31.70M46.00M45.50M35.10M
Operating Cash Flow
68.40M81.00M65.90M80.50M75.70M75.90M
Investing Cash Flow
-57.10M-47.60M-39.40M-30.50M-34.90M-25.40M
Financing Cash Flow
-27.00M-37.30M-40.20M-35.80M-50.40M-32.10M

Chemring Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price373.50
Price Trends
50DMA
358.95
Positive
100DMA
348.39
Positive
200DMA
361.99
Positive
Market Momentum
MACD
3.93
Positive
RSI
51.89
Neutral
STOCH
26.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CHG, the sentiment is Neutral. The current price of 373.5 is below the 20-day moving average (MA) of 383.75, above the 50-day MA of 358.95, and above the 200-day MA of 361.99, indicating a neutral trend. The MACD of 3.93 indicates Positive momentum. The RSI at 51.89 is Neutral, neither overbought nor oversold. The STOCH value of 26.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CHG.

Chemring Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
£119.90B24.5230.27%3.10%-0.76%-12.83%
79
Outperform
£6.39B21.2413.99%2.31%6.10%33.05%
GBCHG
74
Outperform
£1.08B27.6211.62%1.95%8.00%674.47%
GBBA
74
Outperform
$47.49B24.9617.85%1.82%14.01%6.03%
GBRR
72
Outperform
$63.31B22.08
14.70%3.76%
62
Neutral
$8.08B13.633.82%3.13%3.58%-14.35%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CHG
Chemring
373.50
20.09
5.68%
GB:BA
BAE Systems
1,517.50
211.11
16.16%
GB:RR
Rolls-Royce Holdings
659.00
229.90
53.58%
GB:SMIN
Smiths Group plc
1,779.00
222.65
14.31%
GB:ULVR
Unilever
4,694.00
1,000.14
27.08%

Chemring Corporate Events

Business Operations and Strategy
Roke Secures Major UK Missile Defence Contract
Positive
Apr 2, 2025

Roke, a part of Chemring Group PLC, has secured a significant multi-year contract with the UK Ministry of Defence for missile defence, known as the STORM framework. This £251 million contract positions Roke as a key player in the UK’s missile defence ecosystem, enhancing its role in national defence and security by addressing current and future threats such as ballistic and hypersonic missiles. The contract will bolster Roke’s influence in UK defence decision-making and development of next-generation missile defence capabilities, reinforcing its reputation as a trusted partner in solving complex security challenges.

Stock Buyback
Chemring Group PLC Executes Share Buyback Program
Positive
Apr 2, 2025

Chemring Group PLC announced the repurchase of 19,223 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 369.50 to 380.50 pence and will be canceled, potentially enhancing shareholder value and signaling confidence in the company’s financial health.

Regulatory Filings and Compliance
Chemring Group PLC Announces Capital Structure Update
Neutral
Apr 1, 2025

Chemring Group PLC has announced its capital structure as of March 31, 2025, which includes 272,731,749 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights, except in specific situations. This disclosure aligns with the FCA’s rules and assists shareholders in determining their notification obligations regarding their interests in the company.

Stock BuybackBusiness Operations and Strategy
Chemring Group PLC Executes Share Buyback to Optimize Capital Structure
Positive
Apr 1, 2025

Chemring Group PLC has repurchased 20,000 of its ordinary shares at a weighted average price of 371.3588 pence per share as part of its ongoing buyback program. This move, aimed at canceling the shares, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Business Operations and Strategy
Schroders Plc Increases Stake in Chemring Group PLC
Neutral
Mar 31, 2025

Schroders Plc has increased its voting rights in Chemring Group PLC to 5.013396% as of March 28, 2025. This acquisition of voting rights may influence Chemring’s strategic decisions and reflects Schroders’ growing interest in the company’s operations, potentially impacting stakeholder dynamics and market perceptions.

Stock BuybackBusiness Operations and Strategy
Chemring Group Executes Share Buyback to Optimize Capital Structure
Positive
Mar 28, 2025

Chemring Group PLC has repurchased 20,000 of its ordinary shares as part of a buyback program announced earlier in February 2025. The shares were purchased at prices ranging from 377 to 386 pence, with a weighted average price of 381.6539 pence, and are intended to be canceled. This move is part of Chemring’s strategy to optimize its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Chemring Group Executes Share Buyback to Enhance Market Position
Positive
Mar 27, 2025

Chemring Group PLC announced the repurchase of 20,000 of its ordinary shares through Investec Bank plc, with plans to cancel these shares as part of a buyback program initiated in February 2025. This move is likely aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a strategic effort to strengthen its market position.

Stock BuybackBusiness Operations and Strategy
Chemring Executes Share Buyback as Part of Capital Optimization Strategy
Positive
Mar 26, 2025

Chemring Group PLC has executed a buyback of 20,000 ordinary shares at prices ranging from 373.00 to 377.00 pence per share, with a weighted average price of 374.9252 pence. This transaction is part of a previously announced buyback program, and the company plans to cancel the purchased shares, potentially enhancing shareholder value and optimizing capital structure.

Stock Buyback
Chemring Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 25, 2025

Chemring Group PLC has executed a share buyback program, purchasing 19,151 of its ordinary shares at prices ranging from 371.00 to 379.50 pence, with a weighted average price of 374.7598 pence. The company intends to cancel these shares, a move that may positively impact its share value and demonstrate financial stability, potentially benefiting shareholders by increasing earnings per share.

Stock Buyback
Chemring Group Executes Share Buyback Program
Neutral
Mar 24, 2025

Chemring Group PLC announced the purchase of 18,593 of its ordinary shares through Investec Bank plc, as part of a buyback program initiated in February 2025. The shares were bought at a weighted average price of 372.8881 pence and are intended to be canceled, a move that could impact the company’s share value and market perception by reducing the number of shares in circulation.

Stock Buyback
Chemring Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 21, 2025

Chemring Group PLC has executed a share buyback program, purchasing 60,000 of its ordinary shares at prices ranging from 372.50 to 384.50 pence per share, with a weighted average price of 377.9359 pence. The company intends to cancel these shares, which is part of a previously announced buyback program, potentially enhancing shareholder value and optimizing capital structure.

Stock Buyback
Chemring Group PLC Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 20, 2025

Chemring Group PLC announced the repurchase of 59,794 of its ordinary shares at a weighted average price of 388.7913 pence per share as part of its buyback program. The company plans to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of outstanding shares and increasing earnings per share.

Stock BuybackBusiness Operations and Strategy
Chemring Group Executes Share Buyback to Optimize Capital Structure
Positive
Mar 14, 2025

Chemring Group PLC announced the purchase of 17,531 of its ordinary shares through Investec Bank plc, with the intention to cancel these shares as part of a buyback program initiated on 26 February 2025. This move is part of Chemring’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in optimizing its financial operations.

Stock Buyback
Chemring Group Initiates Share Buyback Program
Positive
Mar 13, 2025

Chemring Group PLC has announced a share buyback, purchasing 59,757 of its ordinary shares at a weighted average price of 387.0634 pence per share. This move is part of a previously announced buyback program and aims to cancel the purchased shares, potentially enhancing shareholder value and optimizing the company’s capital structure.

Regulatory Filings and Compliance
Chemring Director Sells Shares, Retains Significant Stake
Neutral
Mar 5, 2025

Chemring Group PLC announced that Sarah Ellard, a director of the company, has sold 27,445 ordinary shares, retaining an interest in 233,000 shares. This transaction is part of the public disclosure requirements for persons discharging managerial responsibilities, reflecting transparency in the company’s operations.

Stock BuybackBusiness Operations and Strategy
Chemring Group Initiates Share Buyback Program
Neutral
Mar 4, 2025

Chemring Group PLC, a company involved in the defense and aerospace industry, has announced the purchase of 20,883 of its ordinary shares through Investec Bank plc, as part of a share buyback program initiated on February 26, 2025. The shares were bought at prices ranging from 380.50 pence to 390.00 pence per share, with a weighted average price of 386.4270 pence. The company plans to cancel the purchased shares, which is a strategic move that may impact its stock value and shareholder equity.

Regulatory Filings and Compliance
Chemring Group PLC Announces Capital Structure Update
Neutral
Mar 3, 2025

Chemring Group PLC has announced its capital structure as of February 28, 2025, consisting of 273,115,575 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights. This information is crucial for shareholders to determine their reporting requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their investments in the company.

Stock Buyback
Chemring Group PLC Executes Share Buyback Program
Positive
Mar 3, 2025

Chemring Group PLC has announced the purchase of 58,159 of its ordinary shares through Investec Bank plc, as part of a buyback program initiated on February 26, 2025. The shares were acquired at prices ranging from 371.50 to 380.00 pence, with a weighted average price of 377.3103 pence. The company plans to cancel these shares, which could potentially enhance shareholder value by reducing the number of shares outstanding and improving earnings per share.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Chemring Group Grants Long-Term Incentive Awards to Directors
Neutral
Feb 27, 2025

Chemring Group PLC has announced the grant of long-term incentive awards to its directors, Michael Ord, James Mortensen, and Sarah Ellard, under the company’s Long Term Incentive Plan. These conditional awards, which involve ordinary shares, are set to vest on December 18, 2027, contingent on continued service and performance conditions. This move, disclosed in the company’s 2024 annual report and approved at the recent Annual General Meeting, reflects Chemring’s commitment to aligning leadership incentives with long-term company performance, potentially impacting its operational focus and stakeholder confidence.

Business Operations and StrategyRegulatory Filings and Compliance
BlackRock Increases Stake in Chemring Group PLC
Neutral
Feb 27, 2025

Chemring Group PLC has announced a change in its major holdings, with BlackRock, Inc. increasing its voting rights in the company to 8.17%. This adjustment in holdings reflects a slight increase from the previous 8.15%, indicating BlackRock’s continued interest and investment in Chemring. The change in voting rights could influence future company decisions and strategies, impacting stakeholders and potentially affecting Chemring’s market positioning within the defense and security sector.

Stock Buyback
Chemring Group Announces Share Buyback Program
Positive
Feb 27, 2025

Chemring Group PLC, a company involved in the defense and aerospace industry, has announced the repurchase of 4,654 ordinary shares through Investec Bank plc, with the intention to cancel these shares. This move is part of a buyback program announced on February 26, 2025, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.

Shareholder MeetingsBusiness Operations and Strategy
Chemring Group PLC Secures Shareholder Approval for AGM Resolutions
Positive
Feb 26, 2025

Chemring Group PLC announced that all resolutions proposed at its Annual General Meeting on 26 February 2025 were passed with the required majority through a poll vote. This outcome reflects strong shareholder support for the company’s strategic direction and governance, potentially reinforcing its position in the defense and security sector. The resolutions, which included both ordinary and special resolutions, will be submitted to the National Storage Mechanism for public inspection.

Stock BuybackBusiness Operations and Strategy
Chemring Group PLC Reports Record Order Book and Announces £40 Million Share Buyback
Positive
Feb 26, 2025

Chemring Group PLC announced an optimistic outlook for FY25, with its order book reaching a record £1,351 million, reflecting strong customer demand across its sectors. The company is well-positioned for future growth, supported by significant orders and a new £40 million share buyback program. The Group’s strategic focus on expanding capacity and capability aligns with the increasing market opportunities, particularly in light of heightened NATO defense spending and European defense production coordination. This strategic direction aims to achieve annual revenue of approximately £1 billion by 2030, with mid-teen margins in the medium term.

Regulatory Filings and Compliance
Chemring Announces Change in BlackRock’s Voting Rights
Neutral
Feb 25, 2025

Chemring Group PLC, a UK-based company, has announced a change in the voting rights held by BlackRock, Inc., a major shareholder. On February 24, 2025, BlackRock’s total voting rights in Chemring decreased from 8.51% to 8.15%, with direct voting rights at 7.04% and indirect rights through financial instruments at 1.11%. This adjustment in BlackRock’s holdings could influence Chemring’s shareholder dynamics and potentially impact its strategic decisions.

Regulatory Filings and Compliance
Chemring Group PLC Announces Change in Voting Rights
Neutral
Feb 21, 2025

Chemring Group PLC, a UK-based company, announced a change in voting rights due to BlackRock, Inc.’s acquisition or disposal of shares. The notification indicates that BlackRock now holds 8.51% of the voting rights in Chemring, an increase from 7.86%. This change could influence Chemring’s shareholder dynamics and affect decision-making processes within the company.

Regulatory Filings and Compliance
Chemring Group PLC Announces Capital Structure and Voting Rights Update
Neutral
Feb 3, 2025

Chemring Group PLC has announced its capital structure as of January 31, 2025, which comprises 273,107,974 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights except in limited cases. This information is crucial for shareholders to determine their reporting obligations under the FCA’s Disclosure and Transparency Rules, potentially impacting shareholder engagement and regulatory compliance.

Shareholder MeetingsFinancial DisclosuresRegulatory Filings and Compliance
Chemring Group Releases 2025 AGM Notice and 2024 Annual Report
Neutral
Jan 27, 2025

Chemring Group PLC has announced the publication of its 2024 Annual Report and Accounts, along with the Notice of its 2025 Annual General Meeting (AGM). These documents are now available to shareholders and can be downloaded from the company’s website. The AGM is scheduled to take place on February 26, 2025, in London. This announcement ensures transparency and compliance with regulatory requirements, reinforcing Chemring’s commitment to governance and stakeholder engagement.

Chemring’s Roke Secures Major US Contract for Radar Altimeters
Jan 14, 2025

Roke, a Chemring subsidiary, has secured a multi-year agreement with a major US Prime Contractor to supply its high-speed Miniature Radar Altimeter (MRA), marking a significant achievement in its strategy to expand revenue from its defense products. The contract, valued at £26 million over four years, underscores Roke’s growing role in space and missile programs, enhancing Chemring’s industry positioning and potentially offering substantial medium-term opportunities worth over £300 million.

Chemring Updates Share Capital and Voting Rights
Jan 2, 2025

Chemring Group PLC has updated its capital and voting rights structure as of December 31, 2024, with a total of 273,084,035 ordinary shares having voting rights and 62,500 cumulative preference shares lacking voting rights except in specific circumstances. This update is relevant for shareholders to assess their interest in compliance with the FCA’s Disclosure and Transparency Rules, impacting shareholder notifications and transparency obligations.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.